Title : Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.

Pub. Date : 2021 Dec 17

PMID : 34589581






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. Fluorouracil epidermal growth factor receptor Homo sapiens
2 Here we report that EGFR and lncRNA-FGD5-AS1 promoted 5-Fu resistance of CRC. Fluorouracil epidermal growth factor receptor Homo sapiens
3 By establishing the 5-Fu-resistant CRC cell line, we detected that EGFR, FGD5-AS1, and glucose metabolism were significantly elevated in 5-Fu-resistant CRC cells. Fluorouracil epidermal growth factor receptor Homo sapiens
4 By establishing the 5-Fu-resistant CRC cell line, we detected that EGFR, FGD5-AS1, and glucose metabolism were significantly elevated in 5-Fu-resistant CRC cells. Fluorouracil epidermal growth factor receptor Homo sapiens
5 Finally, in vitro and in vivo xenograft experiments consistently demonstrated that inhibition of EGFR by the specific inhibitor erlotinib effectively enhanced the anti-tumor toxicity of 5-Fu by targeting the EGFR-FGD5-AS1-miR-330-3p-HK2 pathway. Fluorouracil epidermal growth factor receptor Homo sapiens
6 Finally, in vitro and in vivo xenograft experiments consistently demonstrated that inhibition of EGFR by the specific inhibitor erlotinib effectively enhanced the anti-tumor toxicity of 5-Fu by targeting the EGFR-FGD5-AS1-miR-330-3p-HK2 pathway. Fluorouracil epidermal growth factor receptor Homo sapiens
7 In summary, this study demonstrates new mechanisms of the EGFR-modulated 5-Fu resistance through modulating the noncoding RNA network, contributing to development of new approaches against chemoresistant CRC. Fluorouracil epidermal growth factor receptor Homo sapiens